{
  "url": "https://openlegislation.uk/medicines-products-other-than-veterinary-drugs-general-sale-list-amendment-no-2-order-2001/article-2",
  "json_url": "https://openlegislation.uk/medicines-products-other-than-veterinary-drugs-general-sale-list-amendment-no-2-order-2001/article-2.json",
  "legislation": "uksi/2001/4111",
  "legislation_title": "The Medicines (Products Other Than Veterinary Drugs) (General Sale List) Amendment (No. 2) Order 2001",
  "legislation_url": "https://openlegislation.uk/medicines-products-other-than-veterinary-drugs-general-sale-list-amendment-no-2-order-2001",
  "path": "article/2",
  "kind": "article",
  "number": "2",
  "heading": "Amendment of Table A of Schedule 1 to the principal Order",
  "text": "(1) Table A of Schedule 1 is amended as follows—\n(a) against the entry for Ibuprofen, there is inserted—\n(i) in column 2, after the entry numbered “(2)”, the words “(3) 2.0 per cent”;\n(ii) in column 3, after the entry numbered “(2)”, the words “(3) Internal: liquid preparations, for the treatment of rheumatic or muscular pain, headache, dental pain, feverishness, or symptoms of colds and influenza for use in children aged under 12 years”; and\n(iii) in column 4, after the entry numbered “(2)”, the words “(3) 200 mg (MD) 800 mg (MDD)”; and\n(b) against the entry for Potassium Chloride —\n(i) in column 2, the entry “0.15 per cent” is numbered “(1)”; and\n(ii) in column 3, for the entry “Treatment of acute diarrhoea” there is substituted the entry “(1) Internal: for the treatment of acute diarrhoea” and, after that entry, there is inserted the entry “(2) External”.\n(2) In Table A of Schedule 1, there is inserted in column 1, at the appropriate place in the alphabetical order of the entries as they appear in that column, the entries set out in column 1 below, and, against those entries, there is inserted in columns 2, 3 and 4 the corresponding text in columns 2, 3 and 4 below:\nColumn 1\nColumn 2\nColumn 3\nColumn 4\nSubstance\nMaximum strength or maximum amount released\nUse, pharmaceutical form or route of administration\nMaximum dose and maximum daily dose\nCetirizine Hydrochloride\n10 mg\nTablets; for the symptomatic relief of perennial rhinitis, seasonal allergic rhinitis and idiopathic chronic urticaria in adults and in children aged 12 years and over\n10 mg (MDD)\nIbuprofen Lysine\nEquivalent to 200 mg ibuprofen\nTablets; for the treatment of rheumatic or muscular pain, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness or symptoms of colds and influenza in adults and in children aged 12 years and over\nEquivalent to 400 mg ibuprofen (MD) Equivalent to 1200 mg ibuprofen (MDD)\nLoratadine\n10 mg\nTablets; for the symptomatic relief of perennial rhinitis, seasonal allergic rhinitis and idiopathic chronic urticaria in adults and in children aged 12 years and over\n10 mg (MDD)",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Entry inserted by S.I. 1995/3216 and amended by S.I. 1999/2535."
    },
    {
      "type": "footnote",
      "label": "f2",
      "text": "Entry inserted by S.I. 1998/2170."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2001/4111/article/2",
    "retrieved_at": "2026-10-29T07:17:40.109956+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}